United States Cancer Vaccines Market Report 2016

Publisher Name :
Date: 29-Sep-2016
No. of pages: 121

Notes:

Sales, means the sales volume of Cancer Vaccines

Revenue, means the sales value of Cancer Vaccines

This report studies sales (consumption) of Cancer Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Dendreon

- GlaxoSmithKline

- Merck

- Sanofi

- Vaccinogen

- Vaxon Biotech

- Vical

- Aduro BioTech

- Advantagene

- Advaxis

- Agenus

- AlphaVax

- Altor BioScience

- Amgen

- Antigen Express

- Argos Therapeutics

- Biothera

- Bristol-Myers Squibb

- Celldex Therapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Cancer Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Cancer Vaccines Market Report 2016

Table of Contents
United States Cancer Vaccines Market Report 2016
1 Cancer Vaccines Overview
1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cancer Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Vaccines (2011-2021)
1.4.1 United States Cancer Vaccines Sales and Growth Rate (2011-2021)
1.4.2 United States Cancer Vaccines Revenue and Growth Rate (2011-2021)
2 United States Cancer Vaccines Competition by Manufacturers
2.1 United States Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Cancer Vaccines Market Competitive Situation and Trends
2.4.1 Cancer Vaccines Market Concentration Rate
2.4.2 Cancer Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Cancer Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cancer Vaccines Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Vaccines Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Vaccines Price by Type (2011-2016)
3.4 United States Cancer Vaccines Sales Growth Rate by Type (2011-2016)
4 United States Cancer Vaccines Sales (Volume) by Application (2011-2016)
4.1 United States Cancer Vaccines Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Cancer Vaccines Manufacturers Profiles/Analysis
5.1 Dendreon
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cancer Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
5.2.2 Cancer Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Merck
5.3.2 Cancer Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Cancer Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Vaccinogen
5.5.2 Cancer Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Vaxon Biotech
5.6.2 Cancer Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Vical
5.7.2 Cancer Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Aduro BioTech
5.8.2 Cancer Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Advantagene
5.9.2 Cancer Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Advaxis
5.10.2 Cancer Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Agenus
5.12 AlphaVax
5.13 Altor BioScience
5.14 Amgen
5.15 Antigen Express
5.16 Argos Therapeutics
5.17 Biothera
5.18 Bristol-Myers Squibb
5.19 Celldex Therapeutics
6 Cancer Vaccines Manufacturing Cost Analysis
6.1 Cancer Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cancer Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Cancer Vaccines Market Forecast (2016-2021)
10.1 United States Cancer Vaccines Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Vaccines Sales Forecast by Type (2016-2021)
10.3 United States Cancer Vaccines Sales Forecast by Application (2016-2021)
10.4 Cancer Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Type in 2015
Table Application of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Application in 2015
Figure United States Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure United States Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table United States Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table United States Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Vaccines Revenue Share by Manufacturers
Table 2016 United States Cancer Vaccines Revenue Share by Manufacturers
Table United States Market Cancer Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Vaccines Average Price of Key Manufacturers in 2015
Figure Cancer Vaccines Market Share of Top 3 Manufacturers
Figure Cancer Vaccines Market Share of Top 5 Manufacturers
Table United States Cancer Vaccines Sales by Type (2011-2016)
Table United States Cancer Vaccines Sales Share by Type (2011-2016)
Figure United States Cancer Vaccines Sales Market Share by Type in 2015
Table United States Cancer Vaccines Revenue and Market Share by Type (2011-2016)
Table United States Cancer Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Type (2011-2016)
Table United States Cancer Vaccines Price by Type (2011-2016)
Figure United States Cancer Vaccines Sales Growth Rate by Type (2011-2016)
Table United States Cancer Vaccines Sales by Application (2011-2016)
Table United States Cancer Vaccines Sales Market Share by Application (2011-2016)
Figure United States Cancer Vaccines Sales Market Share by Application in 2015
Table United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Vaccines Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Vaccines Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Vaccines Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Vaccines Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Vaccines Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Vaccines Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Vaccines Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Vaccines Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Vaccines Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Vaccines Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Vaccines Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Vaccines Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Vaccines Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Vaccines Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Vaccines Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Vaccines Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure United States Cancer Vaccines Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Vaccines Production Forecast by Type (2016-2021)
Table United States Cancer Vaccines Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)
    Published: 27-Feb-2017        Price: US 2000 Onwards        Pages: 220
    Executive Summary Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines.Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective......
  • China Rectangle Table Market Research Report 2017
    Published: 23-Feb-2017        Price: US 3200 Onwards        Pages: 121
    Notes: Sales, means the sales volume of Rectangle Table Revenue, means the sales value of Rectangle Table This report studies Rectangle Table in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Steelcase - Herman Miller - Haworth - HNI Group - Okamura Corporation - Kimball Office Market Segment by Regions (prov......
  • China Food Grade Grease Market Research Report 2017
    Published: 23-Feb-2017        Price: US 3200 Onwards        Pages: 120
    Notes: Sales, means the sales volume of Food Grade Grease Revenue, means the sales value of Food Grade Grease This report studies Food Grade Grease in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Shell (The Netherlands) - BP Plc (UK) - Chevron Corporation (US) - Valvoline (US) - Exxon Mobil Corporation (US) - Valvoline (U......
  • China Active Pharmaceutical Ingredients Market Research Report 2017
    Published: 23-Feb-2017        Price: US 3200 Onwards        Pages: 121
    Notes: Sales, means the sales volume of Active Pharmaceutical Ingredients Revenue, means the sales value of Active Pharmaceutical Ingredients This report studies Active Pharmaceutical Ingredients in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Novartis International - Sanofi - Boehringer Ingelheim - Bristol-Myers Squibb......
  • Europe Sodium Fusidate (Cas 751-94-0) Market Report 2017
    Published: 23-Feb-2017        Price: US 3900 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Sodium Fusidate (Cas 751-94-0) Revenue, means the sales value of Sodium Fusidate (Cas 751-94-0) This report studies sales (consumption) of Sodium Fusidate (Cas 751-94-0) in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Wuhan DKY Technology - Kai......
  • Europe Promethazine Hydrochloride Market Report 2017
    Published: 23-Feb-2017        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Promethazine Hydrochloride Revenue, means the sales value of Promethazine Hydrochloride This report studies sales (consumption) of Promethazine Hydrochloride in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Mylan - Endo - Pfizer - ......
  • Europe Metronidazole Benzoate Market Report 2017
    Published: 23-Feb-2017        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Metronidazole Benzoate Revenue, means the sales value of Metronidazole Benzoate This report studies sales (consumption) of Metronidazole Benzoate in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Sanofi - Hubei Maxpharm Industries......
  • United States Herbal Supplements and Remedies Market Report 2017
    Published: 23-Feb-2017        Price: US 3800 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Herbal Supplements and Remedies Revenue, means the sales value of Herbal Supplements and Remedies This report studies sales (consumption) of Herbal Supplements and Remedies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - NBTY(US) - Tsumura(JP) - Weleda(CH) - DSM(NL) - Nature's Sunshine Products(US) - Madaus(DE)......
  • United States Pine Barks Market Report 2017
    Published: 23-Feb-2017        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Pine Barks Revenue, means the sales value of Pine Barks This report studies sales (consumption) of Pine Barks in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Costina - Seaside Mulch - Norfleet Quality - Gro-Bark - Stonewood Products - Armstrong Creek - ... Market Segment by States, coverin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs